tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cidara Therapeutics Reports Positive Trial Results and Financial Growth
PremiumCompany AnnouncementsCidara Therapeutics Reports Positive Trial Results and Financial Growth
7d ago
Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82)
Premium
The Fly
Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82)
8d ago
Cidara Therapeutics price target raised to $115 from $75 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $115 from $75 at RBC Capital
9d ago
Cidara Therapeutics Suspends ATM Prospectus with Jefferies
PremiumCompany AnnouncementsCidara Therapeutics Suspends ATM Prospectus with Jefferies
2M ago
Cidara Therapeutics price target raised to $68 from $50 at Guggenheim
Premium
The Fly
Cidara Therapeutics price target raised to $68 from $50 at Guggenheim
2M ago
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
2M ago
Cidara Therapeutics price target raised to $53 from $41 at H.C. Wainwright
PremiumThe FlyCidara Therapeutics price target raised to $53 from $41 at H.C. Wainwright
2M ago
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
Premium
The Fly
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
2M ago
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100